RAVULIZUMAB
ravulizumab 300 mg/3 mL injection, 3 mL vial
RAVULIZUMAB (15255X)
15255X
Manner of administration:Injection
Restriction
Indication: Acute severe generalised myasthenia gravis (gMG)
Treatment phase: Non-loading/maintenance doses
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 1 | DPMQ: $6,574.12 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Ultomiris | |||||